Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining 0.13% today. In the last week its performance is -1.16%, and 8.21% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of 27.26, so today’s gain of 0.13% is a significant step towards its target price. The GAP today is therefore 0.00%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 32415, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 94.80%.

At the current price of 23.89, it has a dividend yield of *TBA, and its target price is 27.26. This is with a profit margin of -4.30%, and total debt/equity of 0.87. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 19.01.

With a current EPS of -0.26, and a forecasted EPS growth for next year at 14.30%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 13.07%.

Performance for the year is 37.84%. Since its IPO date on 5/19/1992, the total performance to date is 29.39%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 4258606, while its average volume is 10617.66. Whilst the total gain today was 0.13%, it did have a day high of -3.63%.

Volatility for this week has been at 1.22%, and 1.74% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 68.48%, while the 52-week-high has reached -3.63%.

Looking at its return of investments, which is 0.70%, and its return on assets is -1.90%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -7.70%. With a sales growth of 15.40% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.83, and has a current ratio of 1 and 0.7 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.07, along with a P/B of 5.21. Meanwhile it has a p/cash of 74.01.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment